Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.
Stefano CascinuMario ScartozziToshifumi TadaChanghoon YooShigeo ShimoseGianluca MasiSara LonardiLuca Giovanni FrassinetiSilvestris NicolaPiscaglia FabioTakashi KumadaHyung-Don KimHironori KogaCaterina VivaldiCaterina SoldàAtsushi HiraokaYeonghak BangMasanori AtsukawaTakuji TorimuraKunihiko TsujEi ItobayashiHidenori ToyodaShinya FukunishiLorenza RimassaMargherita RiminiStefano CascinuAlessandro CucchettiPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
Present results confirmed randomized controlled trial in the real-life setting, but also suggests that in earlier stages some benefit can be expected.